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in various cellular contexts (Kim and Kimmel, 2000; Fer-
key and Kimelman, 2000; McEwen and Peifer, 2000).
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the paradigm, it is now appreciated that GSK3 regulation
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University College London In Dictyostelium, secreted cAMP serves as a morpho-
gen to direct cell fate specification by stimulating theLondon WCIE 6BT
United Kingdom family of seven-transmembrane, cell surface cAMP re-
ceptors (CARs). The body axis of Dictyostelium is de-
fined by anterior prestalk cells and posterior prespore
cells (Aubry and Firtel, 1999; Kay, 2000; Kim and Kimmel,Summary
2000). GSK3 is required for prespore/spore cell fate
specification but is antagonistic to prestalk/stalk pat-Asymmetric body axis formation is central to meta-
terning, and body axis asymmetry is similarly regulatedzoan development. Dictyostelium establishes an ante-
by CAR3 (Harwood et al. 1995; Plyte et al. 1999) as wellrior/posterior axis utilizing seven-transmembrane
as by the tyrosine kinase ZAK1 (Kim et al. 1999); wecAMP morphogen receptors (CARs) and GSK3-medi-
had previously demonstrated that CAR3 is required toated signal transductions that has a parallel with meta-
activate ZAK1, that CAR3 and ZAK1 are required tozoan Wnt/Frizzled-GSK3 pathways. In Dictyostelium,
activate GSK3, and that ZAK1 can directly phosphory-GSK3 promotes posterior cell patterning but inhibits
late and activate both Dictyostelium and mammaliananterior cell differentiation. Tyrosine kinase ZAK1 me-
GSK3 in vitro (Kim et al. 1999). We had thus suggesteddiates GSK3 activation. We now show that CAR4 regu-
that specific tyrosine phosphorylation (see Kim and Kim-lates a tyrosine phosphatase that inhibits GSK3 activ-
mel, 2001; Woodgett, 2001) was potentially a universality. We have also identified essential phosphotyrosines
mechanism for GSK3 activation and the regulation ofin GSK3, confirmed their role in activated/deactivated
cell fate choice (Kim et al. 1999; Kim and Kimmel, 2000).regulation and cell fate decisions, and relate them to
We now report a cAMP-mediated and protein tyrosinethe predicted 3D structure of GSK3. CARs differen-
phosphatase-dependent pathway in Dictyostelium thattially regulate GSK3 activity by selectively activating a
is antagonistic to GSK3 function and confirm in vivotyrosine phosphatase or kinase for pattern formation.
phosphorylation/dephosphorylation modes for GSK3The findings may provide a comparative understand-
regulation. Signaling through the receptor subtypeing of CAR-GSK3 and Wnt/Frizzled-GSK3 pathways.
CAR4 regulates the protein tyrosine phosphatase to di-
rect the deactivation of GSK3. We have also demon-
Introduction strated that two tyrosine residues within the activation
loop of GSK3 are targets for phosphorylation and that
Morphogen signaling is essential for cell fate specifica- their substitution to phenylanine severely compromises
tion and pattern formation of multicellular organisms. In kinase activity and cAMP-mediated activation. The data
the canonical Wnt pathway, signaling antagonizes the may provide comparative understandings of GSK3-med-
activity of the GSK3 protein kinase (Kim and Kimmel, iated signaling among diverse multicellular organisms and
2000; Ferkey and Kimelman, 2000; McEwen and Peifer, suggest that tyrosine phosphorylation/dephosphorylation
2000; Ali et al., 2001; Woodgett, 2001; Cohen and Frame, may complement other regulatory mechanisms for acti-
2001). While active GSK3 will phosphorylate the tran- vation/deactivation of GSK3 and Wnt-mediated regula-
scriptional cofactor -catenin to direct its destabiliza- tion of cell fate determination and tumorigenesis.
tion, Wnt signaling is functionally inhibitory to GSK3
and thereby stabilizes -catenin to effect transcriptional Results and Discussion
regulation (Wodarz and Nusse, 1998; Kim and Kimmel,
2000; Ferkey and Kimelman, 2000; McEwen and Peifer, CAR4 Signaling Inhibits GSK3 Activity to Establish
2000). Inhibited or active GSK3 will alternatively estab- Anterior Cell Fate Choice
lish dorsal/ventral patterns in vertebrates, posterior/an- Asymmetric anterior/posterior body axis formation in
terior segment polarity in Drosophila, mesoderm/endo- Dictyostelium requires cAMP receptor (CAR) signaling
derm cell fates in C. elegans, and anterior/posterior cell for regulation of cell type-specific gene expression and
fates in Dictyostelium. GSK3 thus serves as an effective for patterning of anterior (prestalk) and posterior (pre-
developmental switch, with GSK3 regulation being part spore) cells. CAR4 is preferentially expressed in anterior/
of an integrated circuit that processes upstream signals prestalk cells, and loss of CAR4 leads to the reduction in
anterior gene expression and the concurrent enhanced
expression of posterior-specific genes (Louis et al.,3 Correspondence: ark1@helix.nih.gov
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Figure 1. Kinase-Inactive GSK3 Acts as a Dominant Negative to Rescue the car4 Null Phenotype
(A) A kinase-inactive mutant of GSK3 has dominant-negative developmental effects. Wild-type (WT), car3 null, and car4 null cells were
differentiated in shaking culture with 50 nM cAMP pulses for 5 hr and then were continuously treated for 6 hr with or without 300 M cAMP
to induce cell-specific gene expression. Northern blot analysis shows the enhanced expression of the anterior prestalk marker ecmA in car3
null cells and reduction of the posterior prespore marker psA. Conversely, psA is highly upregulated in car4 null cells, while ecmA expression
is attenuated. Expression of the K84M, K85M kinase-inactive (KI) GSK3 mutant (see Figure 1B) with the act15 promoter in the car4 null
background suppressed posterior, prespore gene expression but rescued anterior, prestalk expression. No effect on gene expression was
observed using wild-type (WT) GSK3.
(B) The K84M, K85M GSK3 mutant lacks kinase activity. FLAG-tagged wild-type (WT) and FLAG-tagged K84M, K85M (lysine residues involved
in ATP binding) kinase-inactive (KI) mutant GSK3 were expressed in car4 null cells with the act15 promoter and immunopurified with the
-FLAG antibody M2. GSK3 was normalized with -GSK3 antibody and specific GSK3 kinase activities measured with MBP (myelin basic
protein) as a substrate.
(C) car4 null controls () and car4 nulls expressing wild-type (WT) or kinase-inactive (KI) forms of GSK3 were developed on solid substrata
for 15 hr, and expression of the anterior prestalk marker ecmA and the posterior prespore marker psA was determined by Northern blot
hybridization.
(D) car4 null and wild-type cells expressing wild-type (WT) or kinase-inactive (KI) forms of GSK3 were developed on solid substrata to the
mound stage (12 hr) and harvested. Cells were disaggregated and incubated for 6 hr in the presence of 300 M cAMP to induce prespore
gene expression. Expression of the posterior prespore marker psA was determined by Northern blot hybridization.
1994; see Figure 1A). LiCl, an inhibitor of GSK3 (Klein in ecmA expression compared with wild-type, and, con-
versely, they exhibited enhanced differentiation of pos-and Melton, 1996; Stambolic et al., 1996), will promote
anterior and stalk cell fate differentiation in wild-type terior/prespore psA cell patterns (Figure 1A).
If GSK3 were a downstream, negative target of CAR4,cells (Maeda, 1970) and increase anterior gene expres-
sion in car4 nulls (Ginsburg and Kimmel, 1997), sug- then expression of a kinase-inactive (KI) form of
Dictyostelium GSK3 in car4 nulls should rescue thegesting an antagonistic link between CAR4 signaling
and GSK3 function. However, it is well recognized that prestalk gene expression defect. We mutated GSK3 at
two catalytic lysines (see He et al., 1995) that are re-LiCl inhibition is not specific to GSK3. Inositol mono-
phosphatase (IMPase) activity is also sensitive to LiCl, quired for interaction with ATP and showed that it had
no detectable kinase activity (Figure 1B). While expres-and IMPase regulation of inositol and inositide-phos-
phate signaling is required for Dictyostelium develop- sion of wild-type GSK3 had no phenotypic effect, ex-
pression of the KI-GSK3 in car4 nulls reversed the mu-ment (Williams et al., 1999). Using a dominant-negative
form of GSK3, we have now examined more directly tant phenotype (Figure 1A). Anterior/prestalk gene
expression was rescued, whereas GSK3-dependentthe epistatic relationship of CAR4 signaling to GSK3
function. prespore gene expression was specifically and strongly
repressed (Figure 1A). A similar phenotypic rescue wasDictyostelium can be induced to differentiate in shak-
ing culture by treatment with exogenous cAMP (Figure obtained when gene expression patterns of car4 nulls
expressing the KI form of GSK3 were analyzed during1A). Under these conditions, wild-type cells will express
anterior- and posterior-specific genes, respectively, normal development on solid substrata (Figure 1C). Fi-
nally, we show that KI-GSK3 will equivalently suppressprestalk ecmA and prespore psA, while unstimulated
cells will not express these differentiation markers. cAMP-dependent prespore gene expression in both
car4 null and wild-type cells that had been dissociatedCAR4 expression is required for anterior/prestalk differ-
entiation; car4 null cells were extremely compromised from multicellular aggregates (Figure 1D).
Receptor-Dependent, PTPase Inhibition of GSK3
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Figure 2. GSK3 Is a Negative Regulatory Tar-
get Downstream of CAR4
(A) Stalk cell formation in car4 nulls is hyper-
sensitive to cAMP. Wild-type (WT), car4, car3,
zak1, and gsk3 null cells were incubated with
5 mM cAMP for 20 hr in monolayer culture
(Berks and Kay, 1988) and subsequently incu-
bated with 100 nM DIF-1 at varying concen-
trations of cAMP, shown in logarithmic scale,
for an additional 20 hr. The percentage of
vacuolated stalk cells was determined for
each assay and expressed as percent inhibi-
tion compared with cells treated with DIF-1
in the absence of cAMP (80% stalk cells for
WT and 60% stalk cells for car4 nulls). No
inhibition of stalk cell formation by cAMP is
observed for car3, zak1, and gsk3 null cells.
The data represent mean values of two inde-
pendent experiments.
(B) GSK3 activity is upregulated in car4 nulls.
Whole-cell lysates from wild-type (WT), car4,
car3, and gsk3 null cells were prepared
throughout development and GSK3-specific
kinase activities determined by peptide ki-
nase assay. GSK3 was normalized by West-
ern blotting with the -GSK3 antibody 4G-
1E. The data represent mean values of three
independent experiments.
Kinase-inactive GSK3 thus behaves as a dominant- stage of differentiation should suppress GSK3 to po-
tentiate stalk cell formation. Simultaneous activation ofnegative mutant, under all developmental conditions
tested, and rescues the car4 null phenotype. The data GSK3 via CAR3 would inhibit stalk differentiation. In
support, stalk cell formation in car4 nulls was inhibitedsuggest strongly that GSK3 is positioned in a negative
circuit downstream of CAR4 and indicate that a receptor by a cAMP concentration that is three to four orders of
magnitude below that required for inhibition of wild-typeinhibitory signaling pathway functions in Dictyostelium
as a parallel to one mediated by the metazoan Frizzled cells (Figure 2A). cAMP was unable to suppress DIF-1-
mediated stalk cell formation in car3 or gsk3 nulls, cells(Fz) receptors for Wnt ligands (Wodarz and Nusse, 1998;
Ferkey and Kimelman, 2000; Kim and Kimmel, 2000). with inherently diminished GSK3 activity (Harwood et
al., 1995; Plyte et al., 1999; Kim et al., 1999). TheseGSK3 inhibits prestalk/stalk gene expression but acti-
vates prespore/spore gene expression, and, as seen in genetic data further affirm that CAR4 organizes an inhibi-
tory circuit that is antagonistic to CAR3-mediated acti-Figure 1A, loss of CAR3 resulted in the expansion of
prestalk gene expression at the expense of prespore vation of GSK3 and may partially explain the complexity
and antagonism of cAMP/DIF-1 signal/response ingene patterning (Harwood et al., 1995; Plyte et al., 1999;
Kim et al., 1999), a phenotype opposite that of car4 Dictyostelium (Berks and Kay, 1990).
The cell-type specific gene expression patternsnulls. Thus, there appears to be a balance between
CAR4-regulated antagonism toward GSK3 and CAR3- caused by loss of CAR4, together with the epistatic
relationship of GSK3 and CAR4, led us to investigateregulated GSK3 activation. At the terminal stage of dif-
ferentiation, elevated GSK3 activity will repress the DIF- whether GSK3 activity itself were specifically upregu-
lated in cells that lack the antagonistic CAR4 pathway.1-mediated (see Berks and Kay, 1988) stalk cell differen-
tiation pathway (Harwood et al., 1995; Plyte et al., 1999; Growing cells exhibit basal GSK3 activity levels. During
wild-type development, the specific activity of GSK3Kim et al., 1999). Therefore, if CAR4 serves to inhibit
GSK3 activity, cAMP stimulation of CAR4 at the terminal increases2-fold, coincident with the onset of anterior/
Developmental Cell
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Figure 3. Antagonistic Regulation of GSK3 by Tyrosine Phosphorylation and Dephosphorylation
(A) Differential tyrosine phosphorylation of GSK3 by CAR3 and CAR4 regulates GSK3 activity. GSK3 was fused in-frame with the FLAG peptide
and expressed in wild-type (WT), car3, and car4 null cells with the act15 promoter. Cells were differentiated in shaking culture with 50 nM
cAMP pulses for 4 hr and then treated with 300 M cAMP for the times indicated. Whole-cell lysates were prepared throughout the time
course, and GSK3 was immunoprecipitated with -FLAG antibody M2. GSK3 was eluted by FLAG peptide and normalized by Western blotting
with -GSK3 antibody 4G-1E. The same filters were stripped and reprobed using -phosphotytrosine antibody 4G10. GSK3-specific activities
were measured from purified GSK3 with MBP as a substrate.
(B) Relative changes in GSK3 activity levels following cAMP stimulation in an experiment similar to that of Figure 3A. GSK3-specific activity
for each strain at 0 time was set to 100%. GSK3 activity in the gsk3 null strain was compared with that of wild-type cells at 0 time (see Kim
et al. 1999).
posterior cell differentiation (Plyte et al., 1999; Kim et not altered by GSK3 expression (see Figure 1). Under
al., 1999; see also Figure 2B). At later developmental these cell culture conditions, stimulation of wild-type
stages, GSK3 activity returns to near-basal levels (Plyte cells with cAMP induced a rapid increase in both tyro-
et al., 1999; Kim et al., 1999; see also Figure 2B). GSK3 sine phosphorylation and activation of GSK3 (Figures
displayed normal activation in the absence of CAR4 but 3A and 3B). GSK3 activation may be slightly delayed
lacked the terminal inhibitory phase (Figure 2B); ele- relative to phosphorylation, suggesting a dependent re-
vated activity of GSK3 persisted throughout late devel- lationship. GSK3 subsequently underwent a rapid de-
opment. This is consistent with the loss of a CAR4- phosphorylation phase, where in-parallel GSK3 activity
dependent inhibitory pathway for the regulation of GSK3 also returned to basal levels. These data are consistent
activity in car4 nulls. GSK3 activation during early devel- with phosphorylation/dephosphorylation as the antago-
opment requires signaling through CAR3 (Plyte et al., nostic mechanism for activation/deactivation of GSK3.
1999; Kim et al., 1999) and full activation of GSK3 is In car3 null cells GSK3 has a basal level of phosphoryla-
absent in car3 nulls (Figure 2B). Thus, CAR4 and CAR3 tion, but cAMP treatment was unable to activate ZAK1
antagonistically regulate GSK3 at the level of kinase (Kim et al., 1999) or to mediate tyrosine phosphorylation
activity to establish cell fate choice. or activation of GSK3 in vivo (Figures 3A and 3B). The
basal phsophorylation of GSK3 in car3 nulls may derive
from signaling through the closely related receptorCAR4 Inhibition of GSK3 Is Mediated by Tyrosine
CAR1, whose expression is downregulated during thisDephosphorylation
developmental stage.Previous data indicated that activation of GSK3 required
In contrast, while normal cAMP-stimulated tyrosinephosphorylation by the ZAK1 tyrosine kinase (Kim et al.,
phosphorylation and activation of GSK3 were observed1999). We next determined whether the mechanism for
in the absence of CAR4, tyrosine phosphorylation ofCAR4 inhibition of GSK3 involved the regulation in vivo
GSK3 remained elevated and did not decline with timeof tyrosine phosphorylation levels. We expressed FLAG-
in the car4 nulls (Figures 3A and 3B). Furthermore, thetagged GSK3 in wild-type, car3 null, and car4 null cells
persistence of the tyrosine phosphorylation was paral-and monitored the tyrosine phosphorylation state and
leled by a persistence in GSK3 activation throughoutspecific activity of GSK3 following cAMP stimulation of
cultured cells; phenotypes of the parental cell lines were the entire course of the experiment. The absence of
Receptor-Dependent, PTPase Inhibition of GSK3
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Figure 4. Y214 and Y220 of GSK3 Are In Vivo and In Vitro Phosphorylation Sites
(A) Identification of ZAK1 phosphorylation sites in GSK3. GST was fused in-frame with peptides from Dictyostelium GSK3 that contained
tyrosine residues plus flanking sequences. Each construct was separately tested in vitro for its capacity as a ZAK1 substrate. Relative levels
of expressed protein were assessed by Coomassie blue staining.
(B) cAMP-induced phosphorylation of Y214. GSK3 was fused in-frame with the FLAG peptide and expressed in wild-type cells with the act15
promoter. Cells were differentiated in shaking culture with 50 nM cAMP pulses for 4 hr and then treated with 300 M cAMP for the times
indicated. Whole-cell lysates were prepared throughout the time course, and GSK3 was immunoprecipitated with -FLAG antibody M2. GSK3
was eluted by FLAG peptide and normalized by Western blotting with -GSK3 antibody 4G-1E. The same filters were stripped and reprobed
using -pY216 antibody 5G-2F. GSK3-specific activities were measured from purified GSK3 with MBP as a substrate.
(C) Wild-type (WT) and Y214F GSK3 was fused in-frame with the FLAG peptide and expressed in wild-type cells with the act15 promoter.
Whole-cell lysates were prepared from 12 hr mounds and GSK3 was immunoprecipitated using -FLAG antibody M2. GSK3 was eluted
by FLAG peptide and normalized by western blotting using -GSK3 antibody 4G-1E. The same filters were stripped and reprobed with
-phosphotyrosine antibodies 4G10 and PY20.
(D) Identification of ZAK1 phosphorylation sites in GSK3. GST was fused in-frame with peptides from Dictyostelium GSK3 that contained the
specified tyrosine residue. Each construct was separately tested in vitro for its capacity as a ZAK1 substrate. We were unable to obtain a
stable GST fusion with a Y159/Y161 peptide.
dephosphorylation and deactivation of GSK3 that is for its capacity as a ZAK1 substrate. ZAK1 phosphoryla-
tion was very specific; for example, constructs with pep-characteristic of wild-type suggests that cAMP-
tides containing tyrosine 214 (Y216 for mammalianengaged CAR4 downregulates GSK3 activity by direct-
GSK3; see Experimental Procedures for amino aciding a specific loss of ZAK1-mediated tyrosine phosphor-
numbering) and tyrosine 220 (Y222 for mammalianylation.
GSK3) of Dictyostelium GSK3 exhibited strong phos-
phorylation by ZAK1 (Figure 4A), whereas constructs
Critical Tyrosine Phosphorylation Sites Lie within carrying a Y214F mutation that were otherwise identical
the Activation Loop of GSK3 in sequence to wild-type were completely inactive to
Dictyostelium and mammalian GSK3 share 14 (of 16) phosphorylation by ZAK1 (Figure 4A).
tyrosine residues within their respective kinase do- Using an antibody specific for pY214 (pY216 of
mains. We had previously shown that ZAK1 can phos- GSK3), we examined whether Y214 was phosphory-
phorylate and activate both Dictyostelium and mamma- lated in vivo. cAMP induced a rapid increase in Y214-
lian GSK3 in vitro (Kim et al., 1999); these tyrosine specific phosphorylation in wild-type cells expressing
phosphorylation sites are also the postulated targets for FLAG-GSK3, which was temporally parallel to the activa-
CAR4-mediated dephosphorylation and deactivation of tion of GSK3 (Figure 4B). In addition, pY214 was also
GSK3. It is therefore significant to identify the phosphor- dephosphorylated synchronously with the GSK3 deacti-
ylated tyrosines on GSK3 that mediate activation. To vation phase and return to its basal activity state. How-
this end, we have analyzed tyrosine residues within ever, Y214 is not the only tyrosine of GSK3 subject to
Dictyostelium GSK3 in a series of in vitro and in vivo phosphorylation. A Y214F mutant of FLAG-GSK3 was
mapping studies for ZAK1-mediated phosphorylation expressed in Dictyostelium and probed with different
and confirmed their function by expression of mutant -phosphotyrosine antibodies. While 4G10 (or -pY214
GSK3s. [see Figure 5B]) recognizes wild-type GSK3, it fails to
ZAK1 has very strong substrate specificity, and, de- crossreact strongly with Y214F GSK3, suggesting that
spite the numerous tyrosine residues of GST, ZAK1 did 4G10 primarily recognizes pY214 (Figure 4C). However,
not phosphorylate GST in vitro (Figure 4A). GST was -phosphotyrosine-specific antibody PY20 recognizes
fused in-frame with peptides from Dictyostelium GSK3 Y214F GSK3 as well as it recognizes wild-type GSK3,
that contained tyrosine residues and flanking se- suggesting that there are in vivo tyrosine phosphoryla-
tion sites of GSK3 in addition to Y214. Indeed, a GSTquences. Each construct was separately tested in vitro
Developmental Cell
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Figure 5. Y214 and Y220 Are Essential for cAMP-Regulated Phosphorylation and Activation of GSK3
(A) Y214F and Y220F mutations of GSK3 have reduced activity. FLAG-tagged wild-type (WT) and Y214F, Y220F, and Y285F mutants of GSK3
were expressed with the act15 promoter and immunopurified with the -FLAG antibody M2. GSK3 was normalized with -GSK3 antibody,
and specific GSK3 kinase activities were measured with MBP as a substrate.
(B) Y214F and Y220F GSK3 were fused in-frame with the FLAG peptide and expressed in wild-type cells with the act15 promoter. Cells were
differentiated in shaking culture with 50 nM cAMP pulses for 4 hr and then treated with 300 M cAMP for the times indicated. Whole-cell
lysates were prepared throughout the time course, and GSK3 was immunoprecipitated with -FLAG antibody M2. GSK3 was eluted by FLAG
peptide and normalized by Western blotting with -GSK3 antibody 4G-1E. The same filters were stripped and reprobed with -pY216 antibody
5G-2F and with -phosphotytrosine antibody 4G10. GSK3-specific activities were measured from purified GSK3 with MBP as a substrate.
(C) Wild-type cells expressing wild-type (WT), kinase-inactive (KI), or Y214F forms of GSK3 cells were differentiated in culture with 50 nM
cAMP pulses and then continuously treated with or without 300 M cAMP to induce preporel-specific gene expression. Expression of the
prespore marker psA was determined by Northern blot hybridization.
fusion with a Y220 peptide of GSK3 served as a very insensitive to cAMP stimulation. Rather, we only detect a
significant loss of both Y214-specific and total tyrosinestrong substrate for ZAK1 in vitro (Figure 4A). (Additional
phosphorylation sites at Y117, Y125, Y138, Y144, and phosphorylation that matches temporally the decline in
both activity and total tyrosine phosphorylation of wild-Y285/Y286 in Dictyostelium GSK3 that are conserved in
mammalian GSK3 were also detected [see Figure 4D].) type GSK3 (see Figure 3A). Thus, activation of cAMP-
dependent tyrosine dephosphorylation is temporally as-
sociated with GSK3 deactivation and is correlated withTyrosine Phosphorylation Is Required
for GSK3 Activation CAR4 function (see Figures 1, 2, and 3).
These data also indicate that Y214 and Y220 are tar-To determine whether tyrosines Y214 and Y220 within
the activation loop of GSK3 were required for phosphor- gets for cAMP-regulated phosphorylation and that both
pY214 and pY220 are critical elements in the pathwayylation-mediated activation, we expressed wild-type,
Y214F, Y220F, and Y285F forms of FLAG-GSK3 in for GSK3 activation. Y214F, unlike the inactivating KI
mutant of GSK3, retains a minimal, basal enzymatic ac-Dictyostelium and measured their relative activity levels.
Only minimal kinase activity could be detected for the tivity (see Figures 1B and 5A). However, the inability of
Y214F GSK3 to be hyperactivated by cAMP in vivo mayY214F and Y220F mutant forms, whereas Y285F GSK3
had an equivalent specific activity to wild-type GSK3 indicate that it, like KI GSK3, could serve as a partial
dominant negative when expressed in wild-type cells.(Figure 5A). This establishes a functional association of
the Y214 and Y220 sites with GSK3 activity. Y214F and Indeed, both KI GSK3 and Y214F GSK3 suppressed
cAMP/GSK3-dependent expression of the prespore-Y220F FLAG-GSK3-expressing cells were challenged
with cAMP and kinase activities, and phosphotyrosine specific gene psA compared with wild-type GSK3 (Fig-
ure 5C).levels were monitored. Y214F GSK3 has only minimal
basal levels of tyosine phosphorylation and is com- Significantly, tyrosine residues at both 214 and 220
(Y216 and Y222 in mammalian GSK3), which are essen-pletely resistant to cAMP-mediated phosphorylation
and cAMP-mediated activation. Y220F exhibits basal tial for full kinase activity, lie within the activation loop of
GSK3. Recent resolution of the GSK3 crystal structurelevels of Y214-specific and total tyrosine phosphoryla-
tion, similar to that seen with wild-type GSK3 (see Figure (Dajani et al., 2001; ter Haar et al., 2001) may provide
novel insight into potential regulatory mechanisms of3A). As with Y214F GSK3, the activity of Y220F GSK3 is
Receptor-Dependent, PTPase Inhibition of GSK3
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Figure 6. CAR4-Dependent Dephosphorylation of GSK3 Is Mediated by a Protein Tyrosine Phosphatase
(A) ZAK1 is activated transiently in both wild-type and car4 null cells. Tyrosine kinase ZAK1 was FLAG-tagged and expressed in wild-type
and car4 null cells with the act15 promoter. Developmentally competent cells were treated with 300 M cAMP for the times indicated, and
whole-cell lysates were prepared. After ZAK1 purification with M2 antibody, ZAK1 levels for each time point were normalized by Western
blotting with -ZAK1 antibody. The ZAK1-specific activities were measured with MBP as a substrate.
(B) Relative changes in ZAK1 activity levels following cAMP stimulation in an experiment similar to that in (A). ZAK1-specific activity for each
strain at 0 time was set to 100%. ZAK1 activity in the zak1 null strain was compared with that of wild-type cells at 0 time (see Kim et al. 1999).
(C) Absence of cAMP-activated GSK3-specific PTPase in car4 nulls. Developmentally competent cells were treated with 300 M cAMP for
the times indicated, and whole-cell lysates were prepared. Extracts with equivalent protein concentrations were incubated with 32P-Y214
GSK3 peptide in fusion with GST (see Figure 4A). GSK3-specific PTPase activity was measured as a loss of substrate 32P radiolabel, without
a concomitant decrease in total substrate (GST-Y214) mass, as determined by Coomassie blue staining.
(D) Relative changes in PTPase activity levels following cAMP stimulation in an experiment similar to that in (C). PTPase activity for each
strain at 0 time was set to 100%. The data represent mean values of three independent experiments,  4%. Comparative PTPase activity
was determined for wild-type cells and car4 nulls at every time point in the presence of the universal inhibitors sodium vanadate and sodium
molybdate.
GSK3 by tyrosine phosphorylation. The activation loop it is also significant that the Y214F (or Y220F) mutant is
not completely inactive, as is observed with the K84M,of unphosphorylated GSK3 resembles that of activated
(i.e., phosphorylated) ERK2. Phosphotyrosine 185 of K85M mutant (see Figures 1B, 5A, and 5B), yet both
exhibit dominant-negative activities in vivo (Figure 5C).ERK2 makes stable ionic interactions with the positively
charged, neighboring arginines at positions 189 and 192. GSK3 can form an inhibitory homodimer in vitro, with
Y216 at the center of the dimer interface (Dajani et al.,These interactions establish an open conformation for
the activation loop of ERK2 and thereby facilitate substrate 2001; Fraser et al., 2002). If inhibitory dimers form in
vivo, phosphorylation of Y216 and/or Y222 (Y214 andaccess to the active site. Although unphosphorylated
GSK3 exhibits an overall open structural conformation Y220 in Dictyostelium) may disrupt them and serve to
activate GSK3. We recognize the potential that phos-that is similar to activated ERK2, unphosphorylated Y216
of GSK3 (Y214 of Dictyostelium GSK3), the tyrosine phorylation of other tyrosines can also induce conforma-
tional changes and that cooperative and/or hierarchicalcomparable to Y185 of ERK2, is unable to establish
stable interactions with the corresponding arginines phosphomodifications may be required for the maximal
developmentally regulated activation of GSK3.R220 and R223. Upon phosphorylation, however, Y216
may adopt an equivalent conformation to the phospho
form of ERK2 and, thus, fully facilitate substrate access CAR4 Directs Dephosphorylation of GSK3 by
Activating a Protein Tyrosine Phosphatase,to the GSK3 active site (ter Haar et al., 2001; Dajani et
al., 2001). Similarly, phosphorylation of Y222 in GSK3 Not by Inhibiting ZAK1 Kinase
Data suggest that CAR4 mediates an inhibitory pathway(Y220 of Dictyostelium GSK3) may also stabilize confor-
mation of the GSK3 activation loop. that regulates GSK3 tyrosine dephosphorylation and,
consequently, the enzymatic activity of GSK3 (FiguresSeveral reports have shown that the tyrosine phos-
phorylation of GSK3 is critical for kinase activity; mam- 1 and 2). Mechanistically, CAR4 could direct GSK3 de-
phosphorylation/deactivation by inhibiting ZAK1 kinasemalian GSK3 purified from muscle tissue is fully active
and phosphorylated at Y216 (Hughes et al., 1993), and activity, in the presence of a constitutively active protein
tyrosine phosphatase, or CAR4 could mediate the acti-substitution of Y214 or Y220 in Dictyostelium GSK3 is
detrimental to kinase activity (Figures 5A and 5B). But, vation of a GSK3 specific tyrosine phosphatase without
Developmental Cell
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Figure 7. Comparative Cell Fate Choice
Pathways in Xenopus, Drosophila, C. ele-
gans, and Dictyostelium
Vertebrates, Drosophila, C. elegans, and
Dictyostelium share a common develop-
mental dependency on a signaling cascade
that is initiated upon stimulation of an Fz do-
main-containing morphogen receptor that
converges at GSK3. In Xenopus and Dro-
sophila, the morphogen Wnt/Wg initiates an
inhibitory signal that requiries dishevelled
(dsh) and additional components (data not
shown) to functionally downregulate GSK3.
This promotes dorsal fate patterning in Xeno-
pus and posterior segment polarity (naked
cuticle) in Drosophila but antagonizes ventral
pattern formation in Xenopus and anterior
segment polarity (denticle formation) in Dro-
sophila. Other components, including Axin,
mediate the action of active GSK3.
In C. elegans, Wnt signaling activates GSK3.
The Wnt homolog mom-2 initiates a positive
signal cascade from the Fz homolog mom-5 to GSK3. Active GSK3 is required for endoderm formation, while loss of GSK3 function will lead
to a mesodermal fate. Molecular intermediates in this pathway have not been identified.
Dictyostelium, in contrast, employs both positive and negative signaling cascades downstream of its morphogen cAMP receptors to regulate
the common target GSK3. Stimulation of CAR3 activates GSK3 and promotes prespore fate patterns, whereas CAR4 stimulation will inhibit
GSK3 and promote prestalk differentiation. CAR3 activation of GSK3 is mediated by the tyrosine kinase ZAK1, while CAR4 inhibits GSK3 by
a tyrosine phosphatase (PTPase)-dependent pathway. Thus, tyrosine phosphorylation/dephosphorylation of GSK3 mediates antagonistic
receptor regulation for GSK3 activation/deactivation and cell fate determination.
altering ZAK1 activity. To distinguish between these two cells (Figures 6C and 6D). Thus, we conclude that CAR4
inhibition of GSK3 during development is mediated bypathways, we examined ZAK1 regulation in the absence
of CAR4. In wild-type cell cultures, ZAK1 activation by the activation of a specific PTPase that serves to de-
phosphorylate the activating phosphotyrosines withinexogenous cAMP was transient (Figures 6A and 6B),
effectively paralleling the tyrosine phosphorylation and GSK3.
It is significant that activation of the CAR4-regulatedactivation of GSK3 (see Figures 3A and 3B). The absence
of CAR4 signaling had no effect on the temporal kinetics PTPase is delayed relative to that of ZAK1 activation
but is coordinated with ZAK1 and GSK3 deactivationof ZAK1 activation by cAMP or on ZAK1 deactivation.
CAR4 did not inhibit ZAK1 activation, and CAR4 was (see Figure 6A). Thus, the CAR3/ZAK1-dependent phos-
phorylation/activation of GSK3 anticipates the dephos-not required to inactivate ZAK1 precociously. Therefore,
dephosphorylation and deactivation of GSK3 by CAR4 phorylation inhibitory phase regulated by CAR4 and the
PTPase. Effectively, these antagonistic modes for themust occur independently of ZAK1 regulation, indicating
that dephosphorylation of GSK3 is regulated by a spe- regulation of GSK3 are temporally isolated. Finally, it
should also be emphasized that low-level phosphoryla-cific CAR4-dependent signaling cascade that activates
a protein tyrosine phosphatase, leading to GSK3 deacti- tion of Y214 and Y220 of GSK3 persists in both car3
and zak1 null cells. This may suggest the potential forvation.
We have directly assayed for cAMP/CAR4-mediated signal redundancy mediated by additional CARs and
tyrosine kinases.protein tyrosine phosphatase (PTPase) activity using a
phosphotyrosine GSK3 substrate. Extracts were pre-
pared from wild-type and car4 null cells at various times Conclusion: Pathway Conservation between
the cAMP Receptor and Frizzled Familiesfollowing stimulation with cAMP. To determine PTPase
activity levels (see Figures 6C and 6D), we incubated We argue that the differential regulation of tyrosine
phosphorylation of GSK3 by ZAK1 and a PTPase consti-extracts with the Y214 peptide of GSK3 fused with GST
(see Figure 4A) that had been radiolabeled in vitro with tutes the core of regulatory machinery on GSK3 in the
context of cell fate decision by the seven-transmem-ZAK1. Both extracts had significant basal PTPase. This
was seen when PTPase activities were assayed in the brane CARs and suggest that similar mechanistic activi-
ties may function during metazoan development. Thepresence or absence of the universal inhibitors sodium
vanadate and sodium molybdate (Figure 6D). precise conservation of the essential tyrosines between
Dictyostelium and mammalian GSK3 supports the po-In wild-type cells, we observed a significant increase
in PTPase activity that was only apparent after 20 min tential for a common regulatory network controlling
GSK3 activity.of stimulation with cAMP (Figures 6C and 6D). The time
course for this cAMP-dependent PTPase activation cor- Although CARs and Frizzled (Fz) seven-transmem-
brane receptors are activated by different ligands, cAMPrelates well with the cAMP-directed loss of phosphoty-
rosine from GSK3 and the cAMP-directed deactivation and Wnt, respectively, and Fz had been considered a
strictly metazoan receptor, the resemblance of their sig-of GSK3 in vivo (see Figures 3A, 4B, and 5B). Conversely,
no cAMP-activated PTPase was detected in car4 null naling pathways converging at GSK3 (Plyte et al. 1999;
Receptor-Dependent, PTPase Inhibition of GSK3
531
kinase (Kim et al., 1999). The GSK3 peptides were Y56 (sequencesKim et al., 1999) and -catenin (Grimson et al., 2000) for
N52–G60), Y93 (sequences Q89–E97), Y169 (sequences R165–L173),regulating cell fate decisions suggests an ancient origin
Y214 (sequences T210–R218), Y220 (sequences C216–227), Y232for this essential pathway.
(sequences G228–I236), Y285/Y286 (sequences A281–K290), and
In Drosophila and vertebrates, canonical Wnt/Fz sig- Y322 (sequences K318–S326). The published amino acid sequence
naling is inhibitory to GSK3 function, in effective parallel of Dictyostelium GSK3 has a threonine 6-mer, encoded by (ACA/T)6,
in its N-terminal region (Harwood et al., 1995), a region with nowith CAR4. Dominant-negative GSK3 will redirect cell
similarity to mammalian GSK3. The Dictyostelium GSK3 cDNA usedfate choice decision in Xenopus (He et al., 1995; Domin-
in this study had one less trinucleotide repeat; the encoded proteinguez et al., 1995; Yost et al., 1996), as well as in
has only five threonines and is one amino acid shorter in length thanDictyostelium (Figure 1A). In Xenopus, KI-GSK3 is sug-
the published sequence. The positions of all relevant amino acids
gested to compete for association of endogenous GSK3 in this study are downstream of the threonine region and, thus, are
with Axin-based scaffolding complexes (Fraser et al., one amino acid position displaced from that published.
2002). Potentially, such complexes are also essential for
Nucleic Acid AnalysisGSK3 signaling in Dictyostelium. CAR3-mediated acti-
Total RNA blots were as described (Kim et al., 1999). RNAs werevation of GSK3 finds equivalence in C. elegans (Schle-
monitored for integrity and loading equivalency (5 g).singer et al., 1999), where the Fz receptor Mom-5 relays
an activating Wnt (Mom-2) signal to GSK3 (Figure 7). Immunological Techniques and Kinase Assays
It will be very critical to determine whether cell fate -FLAG antibody M2 and FLAG peptide were from Sigma. The GSK3
and ZAK1 kinase assays were described (Kim et al., 1999). Whole-decisions in these other systems are also regulated by
cell lysates of differentiated cells were prepared, and FLAG-GSK3differential tyrosine phosphorylation of GSK3. Although,
or FLAG-ZAK1 was purified. Proteins levels were normalized byto date, C. elegans has the only other positive GSK3
Western blotting with -GSK3 (4G-1E from Upstate) or affinity-puri-cascade yet identified, several mammalian tyrosine ki-
fied polyclonal -ZAK1 serum (Kim et al., 1999), and specific kinase
nases, such as Fyn and Pyk2, are suggested to activate activities were measured with 10 g of MBP (myelin basic protein;
GSK3 (Lesort et al., 1999; Hartigan et al., 2001), raising Sigma). Changes in 32P radiolabel on the substrates were monitored
by PhosphorImager and quantified by ImageQuaNT (Molecular Dy-the possibility that tyrosine phosphorylation of GSK3
namics). Tyrosine phosphorylation of the GSK3 was also monitoredmay mediate antagonism to Wnt signaling to provide
by Western blotting with -phosphotyrosine antibodies 4G10 andadditional regulation for differentiation and tumor sup-
PY20 or with -phospho-Y216-GSK3-specific monoclonal antibodypression (Bienz and Clevers, 2000; Kim et al., 1999; Po-
5G-2F from Upstate.
lakis, 2000, Manoukian and Woodgett, 2002) and that
an activated PTPase may be functionally equivalent to GSK3-Specific PTPase Assays
Wild-type and car4 null cells were pulsed with 50 nM cAMP for 5Wnt signaling to promote tumorigenesis.
hr, stimulated with 300 M cAMP, and lysed in buffer containing 50
mM LiCl, 50 mM imidazole (pH 7.5), 0.5% NP40, 10% glycerol, 0.01%Experimental Procedures
-mercaptoethanol, and protease inhibitor cocktail (complete, Mini
tablet from Roche). One microgram of the ZAK1-radiolabled Y214Dictyostelium Cell Culture and Differentiation
GSK3-GST fusion was incubated for 10 min with 30 g of extractDictysotelium discoidium strain JH10 (see Louis et al., 1994), car3
at 30C. GSK3-specific PTPase activities were measured with thenull cells, and car4 null cells were grown in axenic medium with or
substrate Y214 peptide of GSK3 fused with GST that had beenwithout 100 g/ml of thymidine, as required (Kim et al., 1999; Gins-
radiolabeled in vitro with ZAK1 (see Figure 4A). The loss of 32Pburg and Kimmel, 1997). Cells were developed on nitrocellulose
radiolabel on the substrates was monitored by PhosphorImager andfilters at 1 107 cells per cm2 in DB buffer (10 mM sodium phosphate
quantified by ImageQuaNT (Molecular Dynamics). Sodium vanadate[pH 6.4], 2 mM MgCl2, and 0.2 mM CaCl2). Developing Dictyostelium
(2 mM) and sodium molybdate (80 M) were used as PTPase inhib-was harvested at the given time point, and either protein or RNA
itors.was prepared. Cells at mound stage (12 hr) were collected, dissoci-
ated into single cells, washed, and resuspended at 1  107 cells
Acknowledgmentsper milliliter of DB buffer. Cells were treated either with or without
300 M of cAMP for 6 hr, and RNAs were prepared. To differentiate
We are exceedingly appreciative for the excellent work of Jingchuncells in shaking culture with cAMP, we starved log phase cells for
Liu throughout the course of these studies. We would like to thank1 hr at 2  107 cells per milliliter of DB. Fifty nanomolar pulses of
to Drs. Brian Oliver and Jurrien Dean for their critical comments oncAMP for 6 min intervals were applied to the culture for 4 hr, and
the manuscript. We are also indebted to continued discussions with300 mM of cAMP was added. Cells were harvested at the given
Drs. Joseph Brzostowski, Lisa Kreppel, and Pamela Schwartzberg.time points of each experiments. For stalk cell differentiation in
This work was partially supported by a Wellcome Senior Basic Bio-monolayer culture (Berks and Kay, 1988), cells were plated at 1 
medical Research Fellowship to A.J.H.104 cells/cm2 with 5 mM cAMP. After 20 hr the cAMP medium was
removed and replaced with 100 nM DIF-1 plus varying concentra-
Received: February 13, 2002tions of cAMP.
Revised: July 15, 2002
Molecular Manipulation of GSK3 and ZAK1
ReferencesKinase-inactive GSK3 was constructed by mutating lysine residues
86 and 87, which are required for ATP binding, to methionine. The
Ali, A., Hoeflich, K.P., and Woodgett, J.R. (2001). Glycogen synthaseoligonucleotide for the FLAG peptide (MDYKDDDDK) was sub-
kinase-3: properties, functions, and regulation. Chem. Rev. 101,cloned in-frame with the amino termini of WT, KI, Y241F, and Y220F
2527–2540.GSK3 or ZAK1.
Aubry, L., and Firtel, R. (1999). Integration of signaling networks that
regulate Dictyostelium differentiation. Annu. Rev. Cell Dev. Biol. 15,GST-GSK3 Peptide Fusion and Phosphorylation
469–517.Site Mapping
Bienz, M., and Clevers, H. (2000). Linking colorectal cancer to WntGSK3 peptides were expressed in fusion with GST in E. coli. The
signaling. Cell 103, 311–320.GST fusions were purified by glutathione affinity chromatography
and eluted with 10 mM glutathione. One microgram of each purified Berks, M., and Kay, R.R. (1988). Cyclic AMP is an inhibitor of stalk cell
differentiation in Dictyostelium discoideum. Dev. Biol. 126, 108–114.GST fusion protein was tested in vitro as a substrate for ZAK1
Developmental Cell
532
Berks, M., and Kay, R.R. (1990). Combinatorial control of cell differ- Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837–
1851.entiation by cAMP and DIF-1 during development of Dictyostelium
discoideum. Development 110, 977–984. Schlesinger, A., Shelton, C.A., Maloof, J.N., Meneghini, M., and Bow-
erman, B. (1999). Wnt pathway components orient a mitotic spindleCohen, P., and Frame, S. (2001). The renaissance of GSK3. Nat.
in the early Caenorhabditis elegans embryo without requiring geneRev. Mol. Cell Biol. 2, 769–776.
transcription in the responding cell. Genes Dev. 13, 2028–2038.Dajani, R., Fraser, E., Mark Roe, S.M., Young, N., Good, V., Dale,
Stambolic, V., Ruel, L., and Woodgett, J.R. (1996). Lithium inhibitsT.C., and Pearl, L.H. (2001). Crystal structure of glycogen synthase
glycogen synthase kinase-3 activity and mimics wingless signallingkinase 3: structural basis for phosphate-primed substrate specific-
in intact cells. Curr. Biol. 6, 1664–1668.ity and autoinhibition. Cell 105, 721–732.
ter Haar, E., Coll, J.T., Austen, D.A., Hsiao, H.M., Swenson, L., andDominguez, I., Itoh, K., and Sokol, S.Y. (1995). Role of glycogen
Jain, J. (2001). Structure of GSK3 reveals a primed phosphorylationsynthase kinase 3 beta as a negative regulator of dorsoventral axis
mechanism. Nat. Struct. Biol. 8, 593–596.formation in Xenopus embryos. Proc. Natl. Acad. Sci. USA 92, 8498–
8502. Williams, R.S.B., Eames, M., Ryves, W.J., Viggars, J., and Harwood,
A.J. (1999). Loss of a prolyl oligopeptidase confers resistance toFerkey, D.M., and Kimelman, D. (2000). GSK-3: new thoughts on an
lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J. 18,old enzyme. Dev. Biol. 225, 471–479.
2734–2745.Fraser, E., Young, N., Dajani, R., Franca-Koh, J., Ryves, J., Willimas,
Wodarz, A., and Nusse, R. (1998). Mechanism of Wnt signaling inR.S.B., Yeo, M., Webster, M.-T., Richardson, C., Smalley, M.J., et
development. Annu. Rev. Cell Dev. Biol. 14, 59–88.al. (2002). Identification of the Axin and FRAT/GBP binding region
of glycogen synthase kinase-3. J. Biol. Chem. 277, 2176–2185. Woodgett, J.R. (2001). Judging a protein by more than its name:
GSK-3. Sci STKE. 100, RE12.Ginsburg, G.T., and Kimmel, A.R. (1997). Autonomous and nonau-
Yost, C., Torres, M., Miller, J.R., Huang, E., Kimelman, D., and Moon,tonomous regulation of axis formation by antagonistic signaling via
R.T. (1996). The axis-inducing activity, stability, and subcellular dis-7-span cAMP receptors and GSK3 in Dictyostelium. Genes Dev. 11,
tribution of beta-catenin is regulated in Xenopus embryos by glyco-2112–2123.
gen synthase kinase 3. Genes Dev. 10, 1443–1454.Grimson, M.J., Coates, J.C., Reynolds, J.P., Shipman, M., Blanton,
R.L., and Harwood, A.J. (2000). Adherens junctions and beta-
catenin-mediated cell signalling in a non-metazoan organism. Na-
ture 408, 727–731.
Hartigan, J.A., Xiong, W.C., and Johnson, G.V.W. (2001). Glycogen
synthase kinase 3 is tyrosine phosphorylated by PYK2. Biochem.
Biophys. Res. Commun. 284, 485–489.
Harwood, A.J., Plyte, S.E., Woodgett, J., Strutt, H., and Kay, R.R.
(1995). Glycogen synthase kinase 3 regulates cell fate in Dictyoste-
lium. Cell 80, 139–148.
He, X., Saint-Jeannet, J.P., Woodgett, J.R., Varmus, H.E., and Dawid,
I.B. (1995). Glycogen synthase kinase-3 and dorsoventral patterning
in Xenopus embryos. Nature 374, 617–622.
Hughes, K., Nikolakaki, E., Plyte, S.E., Totty, N.F., and Woodgett,
J.R. (1993). Modulation of the glycogen synthase kinase-3 family by
tyrosine phosphorylation. EMBO J. 12, 803–808.
Kay, R.R. (2000). Development at the edge of multi-cellularity:
Dictyostelium discoideum. Int. J. Dev. Biol. 44, 35–38.
Kim, L., Liu, J., and Kimmel, A.R. (1999). The novel tyrosine kinase
ZAK1 activates GSK3 to direct cell fate specification. Cell 99,
399–408.
Kim, L., and Kimmel, A.R. (2000). GSK3, a master switch regulating
cell fate specification and tumorigenesis. Curr. Opin. Genet. Dev.
10, 508–514.
Klein, P.S., and Melton, D.A. (1996). A molecular mechanism for the
effect of lithium on development. Proc. Natl. Acad. Sci. USA 93,
8455–8459.
Lesort, M., Jope, R.S., and Johnson, G.V. (1999). Insulin transiently
increases tau phosphorylation: involvement of glycogen synthase
kinase-3 and Fyn tyrosine kinase. J. Neurochem. 72, 576–584.
Louis, J.M., Ginsburg, G.T., and Kimmel, A.R. (1994). The cAMP
receptor CAR4 regulates axial patterning and cellular differentiation
during late development of Dictyostelium. Genes Dev. 8, 2086–2096.
Maeda, Y. (1970). Influence of ionic conditions on cell differentiation
and morphogenesis of the cellular slime molds. Dev. Growth Differ.
12, 217–227.
Manoukian, A.S., and Woodgett, J.R. (2002). Role of glycogen syn-
thase kinase-3 in cancer: regulation by wnts and other signaling
pathways. Adv. Cancer Res. 84, 203–229.
McEwen, D.G., and Peifer, M. (2000). Wnt signaling: moving in a
new direction. Curr. Biol. 10, R562–R564.
Plyte, S.E., O’Donovan, E., Woodgett, J.R., and Harwood, A.J. (1999).
Glycogen synthase kinase-3 (GSK-3) is regulated during Dictyoste-
lium development via the serpentine receptor cAR3. Development
126, 325–333.
